Biomarkers Predict Long-Term Outcomes in Juvenile Idiopathic Arthritis

Updated July 18, 2014

James N. Jarvis, MD, clinical professor of pediatrics, is lead author on a study that demonstrates the possibility of using biomarkers in children with juvenile idiopathic arthritis to predict the status of their disease at 12 months.